Loading clinical trials...
Loading clinical trials...
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Conditions
Interventions
Dupilumab
Placebo
Locations
9
United States
University of California San Diego
La Jolla, California, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
Stanford University
Stanford, California, United States
National Jewish Health
Denver, Colorado, United States
University of Florida
Gainesville, Florida, United States
University of Rochester Medical Center
Rochester, New York, United States
Start Date
July 25, 2018
Primary Completion Date
April 3, 2020
Completion Date
September 9, 2020
Last Updated
October 4, 2021
NCT07298395
NCT06928246
NCT07316465
NCT06982352
NCT07235384
NCT07259343
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions